At Reprogram Biosciences, cell reprogramming is at the center of a new way of thinking about therapeutics. Below, Rustam Esanov (CEO) and Eziz Kuliyev (COO) from Reprogram Bio shares—in their own words—how the team is approaching this shift, where they are focusing first, and how partnering with Helix has helped accelerate their work.​ Reprogram’s Mission and Current Focus “To start, could you give a quick overview of Reprogram Biosciences and what your current main project

When Should You Use a Standard LNP Composition versus a Custom Lipid/Polymer Formulation?

In recent conversations with clients, there's been a surge of interest around a rather intriguing subject in the biotech world: lipid nanoparticles (LNPs) and, specifically, the state-of-the-art mixing techniques used in their production. Clients do not know the difference between the turbulent mixing approach and that of microfluidics - they often come to us to enlighten them and explain which one is better! Over the years, our team has witnessed the evolution of numerous m

Lipid nanoparticles (LNPs) are composed of several types of lipids that have been identified and developed for enhanced drug delivery.

Lipid nanoparticles (LNPs) are an advanced non-viral drug delivery system composed of different types of lipids: 1) Ionizable cationic...